Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Gilabert-Estellés, J.
Right arrow Articles by Aznar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilabert-Estellés, J.
Right arrow Articles by Aznar, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 18, No. 7, 1516-1522, July 2003
© 2003 European Society of Human Reproduction and Embryology

Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis

J. Gilabert-Estellés1, A. Estellés2,7, J. Gilabert6, R. Castelló2, F. España2, C. Falcó2, A. Romeu1, M. Chirivella3, E. Zorio4 and J. Aznar5

1 Maternal Hospital, 2 Research Center, 3 Anatomopathology, 4 Cardiology and 5 Clinical Pathology Departments, Hospital Universitario La Fe, and 6 Gynecology Service, Hospital Arnau de Vilanova, Valencia, Spain

7 To whom correspondence should be addressed at: Hospital Universitario ‘La Fe’, Centro de Investigación. Avda. Campanar 21, 46009 Valencia, Spain. e-mail: estelles_amp{at}gva.es

BACKGROUND: Endometriosis is considered a benign disease that has the ability to invade normal tissue. As in neoplastic growth, local extracellular proteolysis may take place. The aim of this study is to analyse several components of the plasminogen activator (PA) pathway and the matrix metalloproteinase (MMP) system in endometriotic tissue, endometrium and peritoneal fluid from women with and without endometriosis (controls). METHODS AND RESULTS: Thirty-nine women with endometriosis and 35 controls were studied. In eutopic endometrium of women with endometriosis, the antigenic levels of urokinase-type PA (uPA) and MMP-3 were elevated when compared with endometrium from controls. Ovarian endometriotic tissues had higher antigenic levels of PA inhibitor type 1 (PAI-1) and tissue inhibitor of metalloproteinases type 1 (TIMP-1) than endometrium. The peritoneal fluid from women with endometriosis showed a significant increase in uPA levels compared with controls. CONCLUSIONS: The increase in antigenic levels of uPA and MMP-3 in endometrium of women with endometriosis might contribute to the invasive potential of endometrial cells. Once the ovarian endometriotic cyst is developed, an increase in PAI-1 and TIMP-1 is detected and significant proteolytic activity is no longer observed. This increase in inhibitors and decrease in proteolytic activity could explain the frequent clinical finding of isolated endometriotic cyst without invasion of the surrounding ovarian tissue.

Key words: endometriosis/MMP-3/PAIs/plasminogen activators/TIMP-1


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
F. Minici, F. Tiberi, A. Tropea, M. Orlando, M. F. Gangale, F. Romani, S. Campo, A. Bompiani, A. Lanzone, and R. Apa
Endometriosis and human infertility: a new investigation into the role of eutopic endometrium
Hum. Reprod., March 1, 2008; 23(3): 530 - 537.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Jensen, B. Sloth, I. Krog-Mikkelsen, A. Flint, A. Raben, T. Tholstrup, N. Brunner, and A. Astrup
A low-glycemic-index diet reduces plasma plasminogen activator inhibitor-1 activity, but not tissue inhibitor of proteinases-1 or plasminogen activator inhibitor-1 protein, in overweight women
Am. J. Clinical Nutrition, January 1, 2008; 87(1): 97 - 105.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. A.B. Klemmt, J. G. Carver, P. Koninckx, E. J. McVeigh, and H. J. Mardon
Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression
Hum. Reprod., December 1, 2007; 22(12): 3139 - 3147.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
S Guay and A Akoum
Stable inhibition of interleukin 1 receptor type II in Ishikawa cells augments secretion of matrix metalloproteinases: possible role in endometriosis pathophysiology
Reproduction, September 1, 2007; 134(3): 525 - 534.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. D. Wren, Y. Wu, and S.-W. Guo
A system-wide analysis of differentially expressed genes in ectopic and eutopic endometrium
Hum. Reprod., August 1, 2007; 22(8): 2093 - 2102.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
J. Gilabert-Estelles, L.A. Ramon, F. Espana, J. Gilabert, V. Vila, E. Reganon, R. Castello, M. Chirivella, and A. Estelles
Expression of angiogenic factors in endometriosis: relationship to fibrinolytic and metalloproteinase systems
Hum. Reprod., August 1, 2007; 22(8): 2120 - 2127.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
K. Shan, Z. Lian-Fu, D. Hui, G. Wei, W. Na, J. Xia, and L. Yan
Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China
Mol. Hum. Reprod., January 1, 2006; 12(1): 35 - 39.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Bellehumeur, T. Collette, R. Maheux, J. Mailloux, M. Villeneuve, and A. Akoum
Increased soluble interleukin-1 receptor type II proteolysis in the endometrium of women with endometriosis
Hum. Reprod., May 1, 2005; 20(5): 1177 - 1184.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
L. Ramon, J. Gilabert-Estelles, R. Castello, J. Gilabert, F. Espana, A. Romeu, M. Chirivella, J. Aznar, and A. Estelles
mRNA analysis of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis using a real-time quantitative RT-PCR assay
Hum. Reprod., January 1, 2005; 20(1): 272 - 278.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. W. Nap, G. A.J. Dunselman, A. F.P.M. de Goeij, J. L.H. Evers, and P. G. Groothuis
Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model
Hum. Reprod., October 1, 2004; 19(10): 2180 - 2187.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Yoshida, T. Harada, M. Mitsunari, T. Iwabe, Y. Sakamoto, S. Tsukihara, Y. Iba, S. Horie, and N. Terakawa
Hepatocyte Growth Factor/Met System Promotes Endometrial and Endometriotic Stromal Cell Invasion via Autocrine and Paracrine Pathways
J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 823 - 832.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.